share_log

Jefferies Downgrades Deciphera Pharmaceuticals to Hold, Lowers Price Target to $25.6

Jefferies Downgrades Deciphera Pharmaceuticals to Hold, Lowers Price Target to $25.6

傑富瑞將Deciphera Pharmicals的評級下調至持有,將目標股價下調至25.6美元
Benzinga ·  04/29 11:15

Jefferies analyst Eun Yang downgrades Deciphera Pharmaceuticals (NASDAQ:DCPH) from Buy to Hold and lowers the price target from $26 to $25.6.

傑富瑞分析師楊恩將Deciphera Pharmicals(納斯達克股票代碼:DCPH)的評級從買入下調至持有,並將目標股價從26美元下調至25.6美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論